This document provides guidance on the use of vasopressors for treating shock. It discusses how to determine if a patient needs vasopressors, appropriate blood pressure goals, choices of initial vasopressor drugs based on the underlying physiology, administration methods, combining and weaning vasopressors, and managing refractory shock. The table provides an overview of common vasopressor drugs including their receptor targets, doses, and clinical applications.
This document provides guidance on the use of vasopressors for treating shock. It discusses how to determine if a patient needs vasopressors, appropriate blood pressure goals, choices of initial vasopressor drugs based on the underlying physiology, administration methods, combining and weaning vasopressors, and managing refractory shock. The table provides an overview of common vasopressor drugs including their receptor targets, doses, and clinical applications.
This document provides guidance on the use of vasopressors for treating shock. It discusses how to determine if a patient needs vasopressors, appropriate blood pressure goals, choices of initial vasopressor drugs based on the underlying physiology, administration methods, combining and weaning vasopressors, and managing refractory shock. The table provides an overview of common vasopressor drugs including their receptor targets, doses, and clinical applications.
This document provides guidance on the use of vasopressors for treating shock. It discusses how to determine if a patient needs vasopressors, appropriate blood pressure goals, choices of initial vasopressor drugs based on the underlying physiology, administration methods, combining and weaning vasopressors, and managing refractory shock. The table provides an overview of common vasopressor drugs including their receptor targets, doses, and clinical applications.
VASOPRESSORS DEMYSTIFIED by Nick Mark MD ONE onepagericu.
com Link to the
most current @nickmmark version → Does this person need vasopressors? EPINEPHRINE • Consider all etiologies of shock (cardiogenic, obstructive, α > β1 = β2 hypovolemic, and distributive); are other treatments (fluids, NOREPINEPHRINE 0.5 – 30 mcg/min blood transfusions, inotropes, etc.) indicated? NOREPINEPHRINE (a.k.a. Levophed, ‘levo’, noradrenaline) • Is there evidence of hypoperfusion? Is BP accurate? DOPAMINE MIXED α/β α > β1 Good general purpose pressor with α > β1 combined vasoconstriction and inotropy Often used first line for septic shock. What is my blood pressure goal? Use mean arterial pressure (MAP) as your goal; target MAP >65 DOBUTAMINE EPINEPHRINE 1 – 10 mcg/min MAP > 60 mmHg may be equivalent to MAP > 65 mmHg in (a.k.a. adrenaline) patients over 65 years old β1 > > α Ideal for anaphylactic shock (also Although higher MAP goals are generally not beneficial, some patients (neurological issues, stenosed coronaries, etc) may (inotropes not vasopressors) PURE β PURE α has bronchodilator activity) Increases lactic acid production benefit from higher individualized MAP goals ISOPROTERENOL PHENYLEPHRINE Β1/ Β2 only VASOPRESSIN 0.01 – 0.06 units/min α only Long half-life; hard to titrate, often used at Which vasopressor to start? Treat the underlying physiology (is a mixed vasoconstriction and a fixed dose. Non-catecholamine pressor; Good adjunct for septic shock inotropy desirable?, High PA pressures ! VASO, Anaphylaxis ! EPI (+) Inotropy Vasoconstriction Unlike other pressors it does not ↑ PA Vasodilation pressures but higher risk for gut ischemia
Push-dose versus continuous infusion Central versus peripheral administration?
Push-dose good for transient hypotension (e.g. post intubation) or PHENYLEPHRINE 50 – 360 mcg/min Do not wait for central access to begin pressors if needed! (a.k.a. Neosynephrine ‘neo’) when pressor infusion is not immediately available. Two options: It is safe and effective to give vasopressors peripherally if: Pure α effects; good for pure • PHENYLEPHRINE syringe (pre-mixed); administer 50-100 mcg • The IV is newly placed, in a larger vein (4mm or larger) and vasodilatory states or in patients who EPINEPHRINE: combine 1 cc of a 10 cc Epi syringe (1:10,000 not in the hand, wrist, or antecubital fossa cannot tolerate inotropy (tachycardia or ACLS dose) with 9 cc of saline (makes 100 mcg epi in 10 cc); • You have a protocol to monitor for extravasation Afib w/ RVR) administer 10-20 mcg at a time (repeat q1 minute) • You know what to do if there is extravasation (protocol) If a patient requires push dose, expect a need for an ongoing PHENYLEPHRINE, NOREPINEPHRINE, EPINEPHRINE can be infusion. given peripherally. (Avoid VASOSPRESSIN peripherally) In the DOPAMINE 1 – 20 mcg/kg/min Mixed effects; May be vasodilatory case of high dose pressors, multiple pressors, or prolonged at low doses (hard to ‘wean’ off) infusion central venous access is recommended. Add additional pressors if needed In patients with cardiogenic shock, Again consider the physiology. Does this person need inotropy? DA is more arrythmogenic than NE. Do they need blood products/fluid? Steroids? Are they acidemic? (requiring > 2 pressors) For sepsis, no benefit to starting in a particular sequence, though NE ! VASO ! EPI ! PHENYL ! DA is common. METHYLENE BLUE Vasopressor refractory shock STEROIDS
CC BY-SA 3.0 v1.2 (2021-02-23)
Am I treating the cause of shock? Stress Dose Steroids Nitric oxide scavenger that can • Consider differential d/dx of shock (e.g. • Hydrocortisone 50 mg q6 hrs IV be used if pressor refractory Weaning vasopressors don’t treat blood loss w/ pressors!) • Wean over days as pressor • 1 – 2 mg/kg SLOW IV push • Acidosis decreases efficacy of pressors! requirement decreases • Good for refractory Wean one pressor at a time; may be advantage to weaning VASO Increase dose of pressors: EPI, NE, DA, • Reduces pressor hypotension or hypotension before NE. Some patients may benefit from adding MIDODRINE PHENYL do not have a true max dose. requirement/duration due to vasoplegia (e.g. after 10 mg 8 hr PO to facilitate weaning from pressors/liberating from Consider stress dose steroids and alternative agents (such as cardiopulmonary bypass) ICU. Consider contraindications and renal dosing. methylene blue, angiotensin II) or interventions (VA ECMO)